Nov 24, 2025 08:00AM
Nov 24, 2025 08:00AM
Nov 13, 2025 06:00AM
Nov 13, 2025 06:00AM
Nov 10, 2025 07:00AM
Nov 4, 2025 04:00PM
Aug 5, 2025 04:00PM Day One Reports Second Quarter 2025 Financial Results and Corporate Progress
Jun 10, 2025 08:31AM
Jun 10, 2025 08:30AM
Jun 2, 2025 06:53AM
May 6, 2025 04:01PM
Feb 25, 2025 04:05PM
Jan 13, 2025 08:15AM
Jan 13, 2025 08:00AM Day One Reports Preliminary 2024 OJEMDA™ Net Product Revenue and Highlights 2025 Corporate Priorities
Oct 30, 2024 04:01PM
Jul 30, 2024 07:30AM
Jul 25, 2024 12:58AM
Jun 18, 2024 08:30AM
May 30, 2024 08:32AM
May 30, 2024 08:30AM
May 6, 2024 04:30PM Day One Reports First Quarter 2024 Financial Results and Corporate Progress
Apr 24, 2024 10:02AM
Apr 24, 2024 09:32AM
Apr 24, 2024 07:11AM
Apr 23, 2024 03:57PM
Apr 23, 2024 03:56PM
Apr 23, 2024 02:12PM
Feb 26, 2024 04:30PM Day One Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Progress
Nov 17, 2023 07:01AM
Nov 17, 2023 07:00AM
Nov 6, 2023 04:30PM
Oct 30, 2023 08:00AM
Sep 11, 2023 08:30AM
Sep 11, 2023 08:30AM
Aug 7, 2023 04:30PM Day One Reports Second Quarter 2023 Financial Results and Corporate Progress
Jun 8, 2023 07:00AM
Jun 5, 2023 07:10AM
Jun 4, 2023 12:45PM
May 25, 2023 08:30PM
May 25, 2023 05:00PM
May 1, 2023 09:00AM
May 1, 2023 09:00AM Day One Reports First Quarter 2023 Financial Results and Corporate Progress
Apr 26, 2023 09:31AM
Apr 26, 2023 09:31AM
Apr 12, 2023 08:00AM
Apr 12, 2023 08:00AM
Mar 6, 2023 04:30PM
Mar 6, 2023 04:30PM
Jan 9, 2023 05:00AM Day One Biopharmaceuticals (DAWN) Reports Strong Topline Data from Pivotal Phase 2 FIREFLY-1 Trial
Jan 8, 2023 05:00PM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All